as on December 20, 2025 at 2:29 am IST
Day's Low
Day's High
0.85%
Downside
1.69%
Upside
52 Week's Low
52 Week's High
19.62%
Downside
34.72%
Upside
Check Elevance Health, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$76.7B
EPS (TTM)
29.986
Dividend Yield
1.12%
Quarterly Earnings Growth YOY
0.22%
PE Ratio (TTM)
13.89
Industry PE ratio
17.123164556962024
PEG Ratio
0.9885
EBITDA
8.9B
Revenue (TTM)
194.8B
Profit Margin
2.84%
Return On Equity TTM
12.57%
Track how Elevance Health, Inc P/E has moved over time to understand its valuation trends.
Elevance Health, Inc in the last 5 years
Lowest (10.14x)
September 30, 2025
Today (13.89x)
December 22, 2025
Industry (17.12x)
December 22, 2025
Highest (17.48x)
December 31, 2022
Today’s Price to Earnings Ratio: 13.89x
Compare market cap, revenue, PE, and other key metrics of Elevance Health, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $76.7B | NA | 13.89 | 2.84% | |
| BUY | $98.7B | 15.62% | 204.53 | 0.12% | |
| BUY | $72.6B | 39.45% | 12.04 | 2.29% | |
| BUY | $296.6B | -2.27% | 17.06 | 4.04% | |
| BUY | $31.2B | -33.22% | 24.27 | 1.02% |
The Elevance Health, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Elevance Health, Inc investment value today
Current value as on today
₹98,277
Returns
Returns from Elevance Health, Inc Stock
Dollar Returns*
₹5,231 (+5.23%)
Based on 26 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 26 analysts, 84.62% of analysts recommend a 'BUY' rating for Elevance Health, Inc. Average target price of $389.21
Get share price movements and forecasts by analysts on Elevance Health, Inc.
What analysts predicted
12.51%UPSIDE
Target Price
$389.21
Current Price
$340.51
Analyzed by
26 Analysts
Target
$389.21
Elevance Health, Inc target price $389.21, a slight upside of 12.51% compared to current price of $340.51. According to 26 analysts rating.
Investment in Elevance Health, Inc Shares on INDmoney has dropped by -61.97% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Elevance Health, Inc Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 17 December
Wed, 06:41 PM
-Elevance Health reports Q3 2025 revenue of $50.1 billion, a 12% year-over-year increase, with diluted EPS at $5.32.
Wed, 08:30 PM
-Elevance Health (ELV) rated 69% based on fundamentals; a score above 80% indicates strong interest.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Elevance Health, Inc has shown consistent revenue growth over the last 7 quarters, with revenues increasing from $42.57 billion to $50.71 billion. This represents an average growth rate of 2.9% per quarter.
Against Peers
![]()
In the last 3 years, Elevance Health, Inc has experienced a drawdown of -33.2%, however Cvs Health Corporation resisted the overall trend and outperformed by 16.4%
Against Peers
![]()
In the last 1 year, Cvs Health Corporation has given 75.2% return, outperforming this stock by 82.1%
Profit Down
![]()
Elevance Health, Inc has experienced a decline in net profit for the last three quarters. The net profit decreased from $2.18 billion to $1.18 billion, indicating an average decrease of 26.0% per quarter.
Price Dip
![]()
In the last 7 days, ELV stock has moved down by -5.5%
| Organisation | Elevance Health, Inc |
| Headquarters | 220 Virginia Avenue, Indianapolis, IN, United States, 46204 |
| Industry | Healthcare |
| CEO | Ms. Gail Koziara Boudreaux |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Scott Wayne Anglin | SVP, Treasurer & Chief Investment Officer |
Mr. Ronald William Penczek | Senior VP, Controller & Chief Accounting Officer |
Mr. Nathan Allen Rich | Vice President of Investor Relations |
Erin M. Wessling | EVP & Chief Legal Officer |
Ms. Felicia Farr Norwood | Executive VP & President of Government Health Benefits |
Ms. Julie Goon | Senior Vice President of Public Affairs |
Ms. Gail Koziara Boudreaux | President, CEO & Director |
Mr. Mark Bradley Kaye | Executive VP & CFO |
Mr. Peter David Haytaian Esq. | Executive VP and President of Carelon & CarelonRx |
Mr. Charles Morgan Kendrick Jr. | Executive VP & President of Commercial Health Benefits |
Elevance Health, Inc share price today is $340.51 as on at the close of the market. Elevance Health, Inc share today touched a day high of $346.27 and a low of $337.61.
Elevance Health, Inc share touched a 52 week high of $458.75 on and a 52 week low of $273.71 on . Elevance Health, Inc stock price today i.e. is closed at $340.51,which is 25.77% down from its 52 week high and 24.41% up from its 52 week low.
Elevance Health, Inc market capitalisation is $0.08T as on .
Indian investors can start investing in Elevance Health, Inc (ELV) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Elevance Health, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Elevance Health, Inc share’s latest price of $340.51 as on December 20, 2025 at 2:29 am IST, you will get 0.0294 shares of Elevance Health, Inc. Learn more about
fractional shares .